Pathological
diagnosis of
lung cancer keep updating and developing, in order to meet the clinical
needs in the era of
precision medicine. It mainly involves the advances of histological subtype
classification,
molecular testing for targeted
therapy,
biomarkers detection for
immunotherapy and the pathological evaluation for
neoadjuvant therapy. Nowadays, pathological
diagnosis of
lung cancer present a multidisciplinary model including
clinical medicine,
radiology and
pathology. It is gradually moving towards
standardization with expection to provide better guidance for clinical
treatment and
prognosis.